| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |